✦ LIBER ✦

469: Prospective, randomized, multicenter trial comparing conversion to a CNI-free regimen (MMF & sirolimus) vs. a CNI-reduced, MMF-based immunosuppression to improve renal function in late cardiac transplant recipients

✍ Scribed by J. Groetzner; U. Schulz; I. Kaczmarek; E. Stegemann; K. Kaiser; M. Voss; T. Wittwer; T.H. Wahlers; J. Schirmer; H.Y. Sohn; H. Welp; C. Schmid; B. Meiser; B. Reichart

Book ID: 116519989
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 63 KB
Volume: 26
Category: Article
ISSN: 1557-3117
DOI: 10.1016/j.healun.2006.11.492

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized controlled trial of late co

A randomized controlled trial of late conversion from calcineurin inhibitor (CNI)-based to sirolimus-based immunosuppression in liver transplant recipients with impaired renal function

✍ Christopher J.E. Watson; Alexander E.S. Gimson; Graeme J. Alexander; Michael E.D 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 307 KB 👁 1 views

Renal impairment is common in patients after liver transplantation and is attributable in large part to the use of calcineurin inhibitor (CNI)-based immunosuppression. We sought to determine whether conversion to sirolimus-based immunosuppression was associated with improved renal function. In a sin